Effects of COVID-19 vaccine type on Guillain-Barré syndrome: Two cases and a literature review

Guillain-Barré syndrome (GBS) is a rare but severe complication of COVID-19 vaccination. We report two cases of GBS following vaccination with the adenovirus vector vaccine ChAdOx1 nCoV-19 (Vaxzevria, AstraZeneca) and review the relevant literature. Relevant studies published between December 2020 a...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Hsin-Yu, Lien, Wan-Ching
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2023
Materias:
Coronavirus
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10026858/
https://www.ncbi.nlm.nih.gov/pubmed/36919452
http://dx.doi.org/10.1080/21645515.2023.2171231

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10026858/
https://www.ncbi.nlm.nih.gov/pubmed/36919452
http://dx.doi.org/10.1080/21645515.2023.2171231

Ejemplares similares